Amylyx Pharmaceuticals, Inc. (AMLX) Holders breakdown
- Shares held by all insiders: Latest value (m).
- Shares held by institutions: Latest value (m).
- Float held by institutions: Latest value (m).
- Institutions holding shares: Latest value (m).
| Breakdown | Latest value |
|---|---|
| Shares held by all insiders | (m) |
| Shares held by institutions | (m) |
| Float held by institutions | (m) |
| Institutions holding shares | (m) |
History
| Date | Shares held by all insiders | Shares held by institutions | Float held by institutions | Institutions holding shares |
|---|---|---|---|---|
| (m) Historical records are unavailable. | ||||
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |